Filters

Generics for sale

Filters

Differentiated strengths

lisdexamfetamine

Capsules 10mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Reference product: Vyvanse
Manufacturer #19112
A pharmaceutical manufacturer based in the EU that develops and produces generic medicines and sells its products in the EU, North America, LATAM, and Africa. Main therapeutic areas include diabetes, urology, and antidepressant. The company possesses its own R&D and regulatory department.

Manufacturer usually replies in 7 days

salbutamol + ipratropium

Nebuliser solution 2.5 mg + 0.5 mg - 2.5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #6580
A pharmaceutical manufacturer based in the EU that has been active in 20+ countries selling its products in Europe, MENA, LATAM, Asia, and NA for 20+ years. Key production lines are Rx and medical devices. Main therapeutic areas include oncology and respiratory. The company's production lines are GMP-compliant.

Manufacturer usually replies in 11 days

dapagliflozin + metformin

Tablets, film coated 5 mg + 850 mg, 5 mg + 1000 mg, 10 mg + 850 mg, 10 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Albania , Armenia , Azerbaijan , Cyprus , Greece , Iraq , Israel , Kazakhstan , Kosovo , Libya , Tajikistan , Uzbekistan , Vietnam
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #17046

It is one of the fastest-growing pharmaceutical firms and a top investor in Rx and Healthcare solutions. The company has been awarded several prizes for its performance and growing business units and has recently been characterized as one of the local economy gems. Based in Europe.

Manufacturer usually replies in 16 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.